Project
Illumina Body Map 2
Navigation
Downloads
Results for FOXM1_TBL1XR1
Z-value: 3.02
Motif logo
Transcription factors associated with FOXM1_TBL1XR1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
|
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOXM1 | hg19_v2_chr12_-_2986107_2986258 | 0.44 | 1.2e-02 | Click! |
| TBL1XR1 | hg19_v2_chr3_-_176914998_176915021 | -0.11 | 5.6e-01 | Click! |
Activity profile of FOXM1_TBL1XR1 motif
Sorted Z-values of FOXM1_TBL1XR1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_+_22748980 | 13.14 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
| chr1_+_117297007 | 10.65 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr2_+_102608306 | 10.52 |
ENST00000332549.3
|
IL1R2
|
interleukin 1 receptor, type II |
| chr1_-_169680745 | 9.37 |
ENST00000236147.4
|
SELL
|
selectin L |
| chr7_+_37888199 | 9.31 |
ENST00000199447.4
ENST00000455500.1 |
NME8
|
NME/NM23 family member 8 |
| chr7_+_142045246 | 8.81 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
| chr14_+_22771851 | 8.74 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
| chr14_+_22520762 | 8.57 |
ENST00000390449.3
|
TRAV21
|
T cell receptor alpha variable 21 |
| chr14_+_22739823 | 8.43 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
| chr14_+_22689792 | 8.42 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
| chr7_-_142198049 | 8.39 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr22_+_22723969 | 8.28 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr14_-_106967788 | 8.06 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr4_-_74847800 | 8.00 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr7_+_142012967 | 7.99 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
| chr22_+_22749343 | 7.54 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr14_+_22191940 | 7.44 |
ENST00000390425.2
|
TRAV3
|
T cell receptor alpha variable 3 (gene/pseudogene) |
| chrX_-_70329118 | 7.28 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr7_+_142031986 | 7.27 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chr5_+_54398463 | 7.12 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr2_+_87565634 | 7.01 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr2_-_90538397 | 6.85 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr12_-_10151773 | 6.81 |
ENST00000298527.6
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1, member B |
| chr2_-_89160117 | 6.68 |
ENST00000390238.2
|
IGKJ5
|
immunoglobulin kappa joining 5 |
| chr22_+_23222886 | 6.67 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr7_-_142131914 | 6.62 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
| chr19_+_51645556 | 6.60 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
| chr14_+_22931924 | 6.56 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
| chr14_+_22446680 | 6.53 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr14_+_22337014 | 6.47 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr12_-_10541575 | 6.46 |
ENST00000540818.1
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1 |
| chr15_-_22448819 | 6.44 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr19_-_54824344 | 6.40 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| chr19_+_42381173 | 6.38 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr1_+_158259558 | 6.36 |
ENST00000368170.3
|
CD1C
|
CD1c molecule |
| chr22_+_23063100 | 6.33 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr1_-_25291475 | 6.30 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
| chr7_+_142000747 | 6.25 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr16_+_30483962 | 6.25 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr2_+_89975669 | 6.18 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr19_-_7766991 | 6.08 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr16_+_30484021 | 5.92 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr14_+_22580233 | 5.86 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
| chr1_+_160709055 | 5.84 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
| chr2_-_89278535 | 5.83 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr11_+_60163918 | 5.73 |
ENST00000526375.1
ENST00000531783.1 ENST00000395001.1 |
MS4A14
|
membrane-spanning 4-domains, subfamily A, member 14 |
| chr6_-_25042390 | 5.72 |
ENST00000606385.1
|
RP11-367G6.3
|
RP11-367G6.3 |
| chr6_+_31540056 | 5.69 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
| chrX_-_55057403 | 5.68 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
| chr7_-_142240014 | 5.60 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
| chr7_-_38305279 | 5.60 |
ENST00000443402.2
|
TRGC1
|
T cell receptor gamma constant 1 |
| chr14_+_22615942 | 5.56 |
ENST00000390457.2
|
TRAV27
|
T cell receptor alpha variable 27 |
| chr7_-_38289173 | 5.53 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr19_+_42381337 | 5.40 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr2_+_90153696 | 5.40 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr4_-_71532207 | 5.39 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr2_+_90024732 | 5.37 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
| chr14_+_22409308 | 5.35 |
ENST00000390441.2
|
TRAV9-2
|
T cell receptor alpha variable 9-2 |
| chr16_+_30484054 | 5.35 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr11_+_60163775 | 5.33 |
ENST00000300187.6
ENST00000395005.2 |
MS4A14
|
membrane-spanning 4-domains, subfamily A, member 14 |
| chr2_-_89442621 | 5.30 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr2_+_90211643 | 5.26 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr18_+_61554932 | 5.25 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| chr17_-_37934466 | 5.24 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr6_-_24799117 | 5.21 |
ENST00000565469.1
|
RP3-369A17.5
|
chromosome 6 open reading frame 229 |
| chr14_-_106453155 | 5.21 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr11_-_104972158 | 5.05 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
| chr7_-_142247606 | 5.04 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr8_-_57472049 | 5.01 |
ENST00000523786.1
ENST00000521483.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr1_+_153175900 | 5.01 |
ENST00000368747.1
|
LELP1
|
late cornified envelope-like proline-rich 1 |
| chr2_+_90273679 | 5.00 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr4_-_48082192 | 4.96 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr14_-_106733624 | 4.94 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr4_-_25865159 | 4.91 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
| chr12_-_9760482 | 4.87 |
ENST00000229402.3
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1 |
| chr5_+_156607829 | 4.87 |
ENST00000422843.3
|
ITK
|
IL2-inducible T-cell kinase |
| chr7_-_142162390 | 4.82 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr7_+_142448053 | 4.82 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
| chr22_+_23264766 | 4.81 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr15_+_58430567 | 4.78 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
| chr2_-_219031709 | 4.77 |
ENST00000295683.2
|
CXCR1
|
chemokine (C-X-C motif) receptor 1 |
| chr8_-_57472154 | 4.76 |
ENST00000499425.1
ENST00000523664.1 ENST00000518943.1 ENST00000524338.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr2_-_89160425 | 4.74 |
ENST00000390239.2
|
IGKJ4
|
immunoglobulin kappa joining 4 |
| chr1_+_160709076 | 4.72 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
| chr2_-_89459813 | 4.68 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr9_+_13446472 | 4.67 |
ENST00000428006.2
|
RP11-536O18.1
|
RP11-536O18.1 |
| chr3_-_112218378 | 4.66 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr19_-_7764281 | 4.65 |
ENST00000360067.4
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr1_-_157670647 | 4.64 |
ENST00000368184.3
|
FCRL3
|
Fc receptor-like 3 |
| chr2_-_89385283 | 4.55 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr9_+_135854091 | 4.52 |
ENST00000450530.1
ENST00000534944.1 |
GFI1B
|
growth factor independent 1B transcription repressor |
| chr22_+_23247030 | 4.51 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr14_-_106725723 | 4.51 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr11_+_60102304 | 4.51 |
ENST00000300182.4
|
MS4A6E
|
membrane-spanning 4-domains, subfamily A, member 6E |
| chr14_+_22694606 | 4.49 |
ENST00000390463.3
|
TRAV36DV7
|
T cell receptor alpha variable 36/delta variable 7 |
| chr17_-_38721711 | 4.47 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr8_-_21771182 | 4.44 |
ENST00000523932.1
ENST00000544659.1 |
DOK2
|
docking protein 2, 56kDa |
| chr7_+_80275621 | 4.40 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr3_+_46412345 | 4.40 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
| chr3_-_112218205 | 4.39 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
| chr2_+_89196746 | 4.39 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
| chr12_+_75874580 | 4.38 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr1_-_28503693 | 4.38 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr11_-_104905840 | 4.37 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
| chr14_-_106539557 | 4.36 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr19_+_49838653 | 4.36 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chrX_-_70331298 | 4.35 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr14_+_22089953 | 4.35 |
ENST00000542354.1
|
TRAV1-1
|
T cell receptor alpha variable 1-1 |
| chr14_-_106518922 | 4.34 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr6_-_133079022 | 4.29 |
ENST00000525289.1
ENST00000326499.6 |
VNN2
|
vanin 2 |
| chr14_+_22386325 | 4.27 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr1_-_179457805 | 4.25 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
| chr2_-_89161432 | 4.23 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
| chr22_+_23161491 | 4.23 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr20_-_1638408 | 4.22 |
ENST00000303415.3
ENST00000381583.2 |
SIRPG
|
signal-regulatory protein gamma |
| chr2_-_89513402 | 4.21 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr3_-_27764190 | 4.20 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
| chr2_-_89327228 | 4.20 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr14_-_107199464 | 4.19 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr8_-_21771214 | 4.17 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
| chr5_-_156390230 | 4.16 |
ENST00000407087.3
ENST00000274532.2 |
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4 |
| chr19_-_54784937 | 4.11 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr16_+_28943260 | 4.10 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr20_-_1638360 | 4.10 |
ENST00000216927.4
ENST00000344103.4 |
SIRPG
|
signal-regulatory protein gamma |
| chr1_-_157670528 | 4.07 |
ENST00000368186.5
ENST00000496769.1 |
FCRL3
|
Fc receptor-like 3 |
| chr9_-_137809718 | 4.06 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
| chr6_+_26383318 | 4.06 |
ENST00000469230.1
ENST00000490025.1 ENST00000356709.4 ENST00000352867.2 ENST00000493275.1 ENST00000472507.1 ENST00000482536.1 ENST00000432533.2 ENST00000482842.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
| chr12_+_9980069 | 4.04 |
ENST00000354855.3
ENST00000324214.4 ENST00000279544.3 |
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1 |
| chr14_+_22217447 | 4.03 |
ENST00000390427.3
|
TRAV5
|
T cell receptor alpha variable 5 |
| chr22_+_23241661 | 4.01 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr5_+_54320078 | 3.99 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr6_+_31674639 | 3.98 |
ENST00000556581.1
ENST00000375832.4 ENST00000503322.1 |
LY6G6F
MEGT1
|
lymphocyte antigen 6 complex, locus G6F HCG43720, isoform CRA_a; Lymphocyte antigen 6 complex locus protein G6f; Megakaryocyte-enhanced gene transcript 1 protein; Uncharacterized protein |
| chr9_+_75766763 | 3.94 |
ENST00000456643.1
ENST00000415424.1 |
ANXA1
|
annexin A1 |
| chr1_-_159046617 | 3.91 |
ENST00000368130.4
|
AIM2
|
absent in melanoma 2 |
| chr19_+_7710774 | 3.90 |
ENST00000602355.1
|
STXBP2
|
syntaxin binding protein 2 |
| chr6_-_32731243 | 3.89 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
| chr22_+_40322595 | 3.89 |
ENST00000420971.1
ENST00000544756.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
| chr7_-_142149390 | 3.88 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
| chr14_-_106471723 | 3.86 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr2_+_152214098 | 3.86 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
| chr4_+_40194570 | 3.85 |
ENST00000507851.1
|
RHOH
|
ras homolog family member H |
| chr13_-_46756351 | 3.84 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr1_-_167059830 | 3.84 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
| chr16_+_85936295 | 3.84 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
| chr7_+_142028105 | 3.83 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
| chr14_-_107114267 | 3.83 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr11_-_118095718 | 3.82 |
ENST00000526620.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr2_+_90077680 | 3.81 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr11_+_65647280 | 3.79 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr7_+_80275953 | 3.79 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr1_+_160765919 | 3.78 |
ENST00000341032.4
ENST00000368041.2 ENST00000368040.1 |
LY9
|
lymphocyte antigen 9 |
| chr7_+_142364193 | 3.77 |
ENST00000390397.2
|
TRBV24-1
|
T cell receptor beta variable 24-1 |
| chr3_+_108541608 | 3.77 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr1_+_160709029 | 3.73 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
| chr2_+_90043607 | 3.73 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
| chr5_+_118691008 | 3.73 |
ENST00000504642.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr2_-_89545079 | 3.71 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr12_-_10022735 | 3.70 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
| chr2_+_204801471 | 3.69 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
| chr22_+_40322623 | 3.69 |
ENST00000399090.2
|
GRAP2
|
GRB2-related adaptor protein 2 |
| chr18_-_68317947 | 3.69 |
ENST00000594039.1
ENST00000582578.1 |
GTSCR1
|
Gilles de la Tourette syndrome chromosome region, candidate 1 |
| chr14_-_106878083 | 3.68 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr1_+_198608146 | 3.67 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr2_-_158345462 | 3.64 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr4_-_71532339 | 3.63 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr14_+_22392209 | 3.62 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr14_-_106830057 | 3.62 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr11_-_118213360 | 3.62 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr2_+_204571198 | 3.61 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
| chr10_-_14646388 | 3.59 |
ENST00000468747.1
ENST00000378467.4 |
FAM107B
|
family with sequence similarity 107, member B |
| chr3_+_114012819 | 3.59 |
ENST00000383671.3
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains |
| chr6_-_31550192 | 3.57 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr14_-_106692191 | 3.56 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr22_+_22516550 | 3.56 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr5_+_118690466 | 3.55 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr12_+_8666126 | 3.54 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
| chr1_+_161677034 | 3.53 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
| chr3_+_108541545 | 3.53 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
| chr2_-_158300556 | 3.52 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
| chr21_+_10862622 | 3.50 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr3_-_46506563 | 3.50 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
| chr11_+_118175132 | 3.50 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr7_-_36764004 | 3.50 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr20_-_56195449 | 3.49 |
ENST00000541799.1
|
ZBP1
|
Z-DNA binding protein 1 |
| chr4_+_68424434 | 3.49 |
ENST00000265404.2
ENST00000396225.1 |
STAP1
|
signal transducing adaptor family member 1 |
| chr11_-_118095801 | 3.48 |
ENST00000356289.5
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
| chr1_-_157522260 | 3.47 |
ENST00000368191.3
ENST00000361835.3 |
FCRL5
|
Fc receptor-like 5 |
| chr8_-_126963487 | 3.47 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr22_+_22786288 | 3.46 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr1_-_153518270 | 3.46 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
| chr6_+_26383404 | 3.45 |
ENST00000416795.2
ENST00000494184.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
| chr2_+_231090471 | 3.42 |
ENST00000373645.3
|
SP140
|
SP140 nuclear body protein |
| chr14_+_22554680 | 3.42 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
| chr1_+_167599330 | 3.40 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
| chr22_+_23029188 | 3.39 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr7_+_142020496 | 3.39 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
| chr6_-_32784687 | 3.39 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr12_+_47610315 | 3.38 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr19_+_7828035 | 3.38 |
ENST00000327325.5
ENST00000394122.2 ENST00000248228.4 ENST00000334806.5 ENST00000359059.5 ENST00000357361.2 ENST00000596363.1 ENST00000595751.1 ENST00000596707.1 ENST00000597522.1 ENST00000595496.1 |
CLEC4M
|
C-type lectin domain family 4, member M |
| chr1_+_209929494 | 3.37 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of FOXM1_TBL1XR1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 22.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 3.5 | 3.5 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 3.4 | 13.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.9 | 8.7 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 2.7 | 16.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 2.6 | 7.9 | GO:0033212 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 2.6 | 7.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.5 | 7.6 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 2.4 | 7.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 2.3 | 25.4 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 2.3 | 9.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 2.2 | 6.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 2.2 | 6.5 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 2.1 | 17.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.1 | 25.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 2.1 | 10.4 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 2.0 | 12.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 2.0 | 23.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.9 | 11.7 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
| 1.9 | 5.7 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.8 | 5.5 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 1.8 | 14.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.8 | 5.5 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 1.8 | 5.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.7 | 6.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 1.7 | 5.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.7 | 1.7 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.7 | 1.7 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.7 | 1.7 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 1.6 | 22.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.6 | 111.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.6 | 4.7 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 1.5 | 1.5 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
| 1.5 | 4.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.5 | 4.4 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.4 | 8.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 1.4 | 7.0 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.4 | 4.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.4 | 12.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.3 | 8.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.3 | 5.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 | 4.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 1.3 | 1.3 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
| 1.3 | 5.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.3 | 6.6 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 1.3 | 5.1 | GO:0052362 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 1.3 | 6.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 1.3 | 2.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.3 | 3.8 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
| 1.2 | 146.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.2 | 6.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.2 | 1.2 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.2 | 6.0 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 1.2 | 1.2 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 1.1 | 5.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.1 | 5.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.1 | 4.5 | GO:0070340 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.1 | 5.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.1 | 5.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 1.1 | 10.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 1.0 | 1.0 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 1.0 | 2.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 1.0 | 6.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.0 | 4.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.0 | 4.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 1.0 | 3.8 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.9 | 5.7 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.9 | 1.9 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.9 | 6.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.9 | 11.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.9 | 1.8 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.9 | 2.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.9 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.9 | 2.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.9 | 0.9 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.9 | 21.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.9 | 6.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.9 | 3.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.9 | 3.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.9 | 1.7 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.9 | 1.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.9 | 5.2 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
| 0.9 | 0.9 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.8 | 2.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.8 | 3.3 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.8 | 2.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.8 | 7.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.8 | 2.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.8 | 3.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.8 | 6.5 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
| 0.8 | 2.5 | GO:2000427 | positive regulation of engulfment of apoptotic cell(GO:1901076) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.8 | 11.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.8 | 0.8 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.8 | 3.2 | GO:0018277 | protein deamination(GO:0018277) |
| 0.8 | 166.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.8 | 9.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.8 | 5.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.8 | 14.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.8 | 1.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.8 | 2.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.8 | 2.4 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.8 | 5.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.8 | 3.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.8 | 0.8 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.8 | 0.8 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.8 | 2.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.8 | 2.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.8 | 2.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.8 | 6.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.8 | 2.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.8 | 7.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.8 | 1.5 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.7 | 2.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.7 | 5.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.7 | 3.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.7 | 5.1 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) |
| 0.7 | 1.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.7 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 | 0.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.7 | 1.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 | 2.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.7 | 2.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.7 | 3.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.7 | 9.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.7 | 2.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.7 | 15.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 0.7 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.7 | 1.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.7 | 2.8 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.7 | 4.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.7 | 3.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.7 | 1.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.7 | 6.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.7 | 2.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.7 | 6.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.7 | 8.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.7 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.7 | 21.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.7 | 9.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.7 | 5.9 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.7 | 10.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 | 2.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.7 | 1.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 | 1.3 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.6 | 1.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.6 | 3.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.6 | 1.9 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.6 | 7.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.6 | 1.9 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.6 | 1.3 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.6 | 5.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 | 3.2 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.6 | 6.3 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.6 | 5.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.6 | 1.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 | 1.2 | GO:2000418 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.6 | 1.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.6 | 10.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 | 2.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.6 | 3.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.6 | 1.2 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.6 | 0.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.6 | 1.8 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.6 | 8.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.6 | 5.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 1.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.6 | 4.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 | 2.3 | GO:0060032 | notochord regression(GO:0060032) |
| 0.6 | 1.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.6 | 1.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.6 | 0.6 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.6 | 2.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.5 | 2.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.5 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.5 | 7.1 | GO:0001562 | response to protozoan(GO:0001562) |
| 0.5 | 4.4 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.5 | 1.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.5 | 2.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.5 | 1.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.5 | 2.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.5 | 1.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 | 4.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.5 | 1.1 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.5 | 7.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.5 | 2.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.5 | 4.7 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.5 | 1.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 4.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.5 | 7.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.5 | 1.5 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.5 | 12.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.5 | 7.8 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.5 | 3.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 1.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.5 | 0.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.5 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.5 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.5 | 3.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.5 | 3.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 1.4 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.5 | 1.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 | 5.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.5 | 3.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.5 | 1.4 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.5 | 1.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.5 | 6.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.5 | 0.9 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 | 1.9 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.5 | 0.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.5 | 50.1 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.5 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.5 | 3.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.5 | 0.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
| 0.5 | 0.5 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.5 | 0.9 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.4 | 0.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 0.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.4 | 4.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.4 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 | 2.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 | 19.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.4 | 6.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 2.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 | 31.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.4 | 1.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.4 | 5.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.4 | 5.6 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.4 | 1.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 2.1 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.4 | 1.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.4 | 1.7 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.4 | 5.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.4 | 3.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.4 | 1.7 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.4 | 2.5 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.4 | 5.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 1.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.4 | 0.8 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.4 | 1.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.4 | 2.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.4 | 1.2 | GO:0060345 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.4 | 1.2 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.4 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.4 | 1.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.4 | 2.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.4 | 1.6 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.4 | 1.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.4 | 6.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.4 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.4 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 1.2 | GO:0048925 | lateral line system development(GO:0048925) |
| 0.4 | 5.6 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.4 | 2.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.4 | 3.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 2.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.4 | 1.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.4 | 3.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.4 | 1.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.4 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 1.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 | 17.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.4 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.4 | 1.1 | GO:1905133 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
| 0.4 | 3.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.4 | 30.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.4 | 1.9 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.4 | 6.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.4 | 1.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.4 | 0.4 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 0.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.4 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 1.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 0.4 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.4 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.4 | 1.9 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.4 | 3.7 | GO:0072678 | T cell migration(GO:0072678) |
| 0.4 | 8.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.4 | 1.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 | 2.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.4 | 10.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.4 | 0.7 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.4 | 1.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.4 | 1.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.4 | 1.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.4 | 10.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.4 | 1.1 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.4 | 1.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.4 | 1.1 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.4 | 4.6 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.4 | 18.3 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.4 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 4.2 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.3 | 2.4 | GO:0001554 | luteolysis(GO:0001554) |
| 0.3 | 1.7 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 1.0 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.3 | 2.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 3.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.3 | 2.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.3 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.3 | 1.0 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.3 | 6.1 | GO:0010042 | response to manganese ion(GO:0010042) |
| 0.3 | 1.0 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 | 1.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 1.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 2.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) negative regulation of T cell apoptotic process(GO:0070233) |
| 0.3 | 1.0 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.3 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.3 | 6.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.3 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 | 1.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.3 | 0.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.3 | 1.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.3 | 1.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.3 | 0.3 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.3 | 0.3 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.3 | 2.6 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.3 | 1.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.3 | 1.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 0.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.3 | 1.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.3 | 0.6 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
| 0.3 | 2.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 0.6 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.3 | 0.3 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) |
| 0.3 | 1.3 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.3 | 3.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.3 | 0.9 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.3 | 5.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 1.9 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 | 6.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.3 | 2.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 0.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.3 | 1.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 | 1.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 | 1.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.3 | 0.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.3 | 7.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.3 | 2.8 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 3.7 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.3 | 1.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.3 | 0.6 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.3 | 0.9 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.3 | 5.4 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 0.3 | 4.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.3 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
| 0.3 | 6.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.3 | 2.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 12.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.3 | 1.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.3 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.3 | 0.9 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 0.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 | 0.3 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.3 | 1.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 0.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.3 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 1.4 | GO:0048880 | sensory system development(GO:0048880) |
| 0.3 | 1.7 | GO:0010756 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.3 | 45.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.3 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 6.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 | 1.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.3 | 0.8 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.3 | 0.6 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.3 | 1.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 | 3.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 2.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 0.8 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 0.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 | 9.5 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.3 | 0.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.3 | 0.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.3 | 1.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.3 | 1.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.3 | 0.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.3 | 0.3 | GO:0016233 | telomere capping(GO:0016233) |
| 0.3 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 0.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 0.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 | 0.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 1.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.3 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.3 | 4.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 1.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 | 0.5 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.3 | 2.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.3 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.3 | 1.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 | 0.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.3 | 1.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.3 | 0.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 0.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 0.5 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.3 | 0.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
| 0.3 | 1.6 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.3 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.3 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.3 | 1.8 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.3 | 2.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.3 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.3 | 1.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.3 | 3.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.3 | 3.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 | 1.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.3 | 6.4 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.3 | 1.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.3 | 2.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 1.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 0.3 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced neuron death(GO:1903223) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.3 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 0.2 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.2 | 0.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.2 | 1.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 1.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 0.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.2 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 | 1.7 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 1.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 0.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.2 | 4.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 1.0 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 1.0 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.2 | 1.4 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 1.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.2 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 1.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 1.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 1.0 | GO:0007276 | gamete generation(GO:0007276) |
| 0.2 | 1.0 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.2 | 0.5 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.2 | 10.7 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.2 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 | 0.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.2 | 0.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.2 | 1.9 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.2 | 4.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.2 | 5.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.2 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.2 | 0.7 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 | 1.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.2 | 0.2 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.2 | 0.5 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 19.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 2.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.2 | 8.0 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.2 | 0.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 | 0.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.2 | 0.4 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.2 | 39.0 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.2 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 0.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.2 | 2.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.2 | 0.7 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 1.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.2 | 0.7 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
| 0.2 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.2 | 1.3 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.2 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 1.1 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.2 | 1.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 9.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 | 0.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.2 | 0.4 | GO:0048538 | thymus development(GO:0048538) |
| 0.2 | 3.0 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.2 | 8.0 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 | 3.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.2 | 0.4 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 1.1 | GO:0009624 | response to nematode(GO:0009624) |
| 0.2 | 0.2 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 0.2 | 0.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 | 0.2 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.2 | 0.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 4.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 5.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 0.6 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 2.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.2 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 2.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.2 | 1.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.2 | 0.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 | 1.2 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.2 | 0.8 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.2 | 1.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 | 0.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 0.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 1.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.2 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 1.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.2 | 3.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 4.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.2 | 0.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 2.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 0.8 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.2 | 1.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.2 | 0.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
| 0.2 | 5.7 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 0.6 | GO:0001906 | cell killing(GO:0001906) |
| 0.2 | 0.8 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 | 1.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 1.9 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
| 0.2 | 1.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.2 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 | 0.9 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 0.6 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 | 1.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 | 0.9 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.2 | 0.2 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.2 | 0.6 | GO:0071283 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) cellular response to iron(III) ion(GO:0071283) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.2 | 0.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
| 0.2 | 1.3 | GO:2000784 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.2 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) |
| 0.2 | 0.7 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 0.2 | 0.9 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.2 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 | 0.5 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.2 | 1.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.2 | 0.4 | GO:0052031 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 | 0.7 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.2 | 0.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
| 0.2 | 0.2 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.2 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 0.4 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.2 | 3.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.2 | GO:0031341 | regulation of cell killing(GO:0031341) |
| 0.2 | 3.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 4.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.2 | 1.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 | 5.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.2 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.2 | 1.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.2 | 0.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 1.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.2 | 3.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.2 | 2.3 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.5 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 3.1 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 0.7 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.2 | 6.0 | GO:0030317 | sperm motility(GO:0030317) |
| 0.2 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 0.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 1.5 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.2 | 0.8 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 3.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.2 | 1.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.2 | 2.5 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.2 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 | 0.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.2 | 0.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 0.7 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.2 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 0.5 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 0.3 | GO:0071453 | cellular response to oxygen levels(GO:0071453) |
| 0.2 | 0.8 | GO:0045007 | depurination(GO:0045007) |
| 0.2 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.2 | 0.5 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.2 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
| 0.2 | 0.8 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.2 | 1.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.2 | 0.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 0.6 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.2 | 0.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.2 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 0.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 0.6 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 0.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 | 90.7 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.2 | 0.8 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.8 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
| 0.2 | 1.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.2 | 0.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.2 | 1.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.2 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 0.5 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.2 | 1.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 | 0.5 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.2 | 0.5 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
| 0.2 | 0.8 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.2 | 0.8 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.2 | 3.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 0.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.1 | 4.0 | GO:1903039 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
| 0.1 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 1.3 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.1 | 0.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 1.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.1 | 0.9 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 2.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.1 | 0.9 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 | 10.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
| 0.1 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.1 | 2.7 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
| 0.1 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 6.7 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
| 0.1 | 0.8 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.1 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.1 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
| 0.1 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.5 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.8 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 1.0 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.4 | GO:0071281 | cellular response to iron ion(GO:0071281) |
| 0.1 | 3.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.1 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.1 | 2.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 1.5 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.1 | 1.1 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
| 0.1 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.1 | 1.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 2.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.4 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 2.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.1 | 0.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 | 0.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.1 | 2.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 1.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.6 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.1 | 0.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 | 2.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.1 | 1.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 | 0.9 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
| 0.1 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.1 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 0.1 | 0.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 2.2 | GO:0032963 | collagen metabolic process(GO:0032963) |
| 0.1 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.1 | 1.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 1.0 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.6 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 | 0.1 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.2 | GO:0036118 | hyaluranon cable assembly(GO:0036118) extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.1 | 0.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.3 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 0.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.1 | 1.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.1 | 1.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 | 0.7 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 2.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 2.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.2 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 2.3 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.1 | 0.6 | GO:0008217 | regulation of blood pressure(GO:0008217) |
| 0.1 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 | 0.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.6 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 1.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 0.8 | GO:0009445 | putrescine metabolic process(GO:0009445) |
| 0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 3.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.1 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 2.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 1.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.5 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 1.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.6 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.2 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.6 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.1 | 0.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.1 | 2.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 1.9 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.1 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
| 0.1 | 1.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 1.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.2 | GO:0061025 | membrane fusion(GO:0061025) |
| 0.1 | 0.7 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 | 0.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 3.4 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 | 0.4 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 | 2.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 1.3 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 0.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.1 | 6.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 | 5.7 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.3 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
| 0.1 | 0.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 2.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.3 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
| 0.1 | 1.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.3 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 | 1.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.1 | 1.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.4 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.1 | 0.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.1 | 0.6 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.1 | 0.9 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.1 | 0.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 0.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.1 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.1 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 1.9 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
| 0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 0.4 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 2.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.2 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.1 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 5.4 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.1 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 0.5 | GO:0090208 | positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 | 1.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 2.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 1.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.3 | GO:0060938 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.1 | 0.2 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 0.9 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.1 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 0.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 1.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.7 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) |
| 0.1 | 0.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 | 0.3 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.1 | 1.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 | 5.3 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.1 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 0.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 1.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.1 | 0.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.2 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 0.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 11.9 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 1.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 1.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.1 | 1.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.1 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 | 1.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 1.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.1 | 0.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.9 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.1 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 1.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.6 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 3.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 45.1 | GO:0007283 | spermatogenesis(GO:0007283) |
| 0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.1 | 1.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 1.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.4 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.1 | 3.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.3 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 3.7 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 | 0.1 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.1 | 0.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.1 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.1 | 0.4 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.1 | 0.1 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.1 | 0.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.1 | 0.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
| 0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 2.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 1.7 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.1 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 0.2 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 | 0.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.1 | 0.3 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 2.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 0.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.3 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 2.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.3 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.3 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 | 6.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.1 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 1.0 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 1.7 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.1 | 0.6 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 | 0.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 1.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 3.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.1 | 2.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.1 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
| 0.1 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.1 | 0.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.2 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.1 | 2.7 | GO:0070671 | response to interleukin-12(GO:0070671) |
| 0.1 | 0.5 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 | 0.3 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.1 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 0.2 | GO:0060425 | lung morphogenesis(GO:0060425) |
| 0.1 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.3 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.1 | 1.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.2 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 1.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.1 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.2 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 | 0.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
| 0.1 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 0.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 0.4 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.1 | 0.8 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
| 0.1 | 0.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.1 | 0.6 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.1 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
| 0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.1 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) multi-organism localization(GO:1902579) |
| 0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.0 | 0.2 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
| 0.0 | 0.1 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.1 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.0 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.0 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.0 | 0.0 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.0 | 0.2 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.0 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 | 0.1 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) negative regulation of cyclic nucleotide catabolic process(GO:0030806) regulation of cAMP catabolic process(GO:0030820) negative regulation of cAMP catabolic process(GO:0030821) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.0 | 0.2 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 1.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 | 28.2 | GO:0006955 | immune response(GO:0006955) |
| 0.0 | 0.1 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
| 0.0 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 0.8 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.0 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.1 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.0 | 0.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.0 | 0.8 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 0.2 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.0 | 1.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.2 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
| 0.0 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
| 0.0 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.0 | 0.5 | GO:1901724 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) positive regulation of glomerulus development(GO:0090193) positive regulation of cell proliferation involved in kidney development(GO:1901724) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.0 | 0.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 1.1 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.0 | 0.2 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.0 | 0.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) erythrocyte homeostasis(GO:0034101) |
| 0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.0 | 0.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.0 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.0 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 | 0.1 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 | 0.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.2 | GO:0051216 | cartilage development(GO:0051216) |
| 0.0 | 0.2 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.0 | 0.5 | GO:0042098 | T cell proliferation(GO:0042098) |
| 0.0 | 0.1 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.4 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.0 | 1.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.0 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.0 | 0.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.0 | 0.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.1 | GO:1902913 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 | 0.1 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
| 0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 0.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.0 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 | 1.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 | 0.1 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 | 0.4 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.0 | 0.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.0 | 0.1 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.0 | 0.1 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.1 | GO:2000113 | negative regulation of cellular macromolecule biosynthetic process(GO:2000113) |
| 0.0 | 0.2 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
| 0.0 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.0 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
| 0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 | 1.6 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 | 0.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 | 0.1 | GO:0072075 | metanephric mesenchyme development(GO:0072075) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 | 1.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.1 | GO:2001202 | negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.0 | 0.1 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.0 | 0.5 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:0014902 | myotube differentiation(GO:0014902) |
| 0.0 | 0.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 | 0.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.0 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
| 0.0 | 0.0 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.9 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.0 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.0 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 0.0 | 0.1 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.0 | 0.0 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
| 0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 | 0.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.0 | 0.1 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
| 0.0 | 0.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 | 0.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 1.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.0 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.0 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.2 | GO:0006342 | chromatin silencing(GO:0006342) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 9.3 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 2.9 | 8.6 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 2.5 | 22.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 2.5 | 7.5 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 2.2 | 24.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 2.1 | 108.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 2.1 | 14.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 1.7 | 5.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.6 | 11.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.5 | 55.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.5 | 4.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 1.4 | 12.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 1.4 | 7.0 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.4 | 5.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 1.3 | 3.9 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 1.3 | 5.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 1.3 | 1.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 1.2 | 3.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 1.2 | 2.4 | GO:0030120 | vesicle coat(GO:0030120) |
| 1.1 | 4.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.1 | 24.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.0 | 3.0 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.0 | 1.0 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.9 | 1.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.9 | 14.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.9 | 5.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.9 | 12.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.9 | 7.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.8 | 3.2 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.8 | 8.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.8 | 4.7 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.7 | 31.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.7 | 2.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.7 | 2.9 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.7 | 4.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.6 | 1.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.6 | 1.9 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.6 | 2.5 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.6 | 19.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.6 | 1.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.6 | 8.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.6 | 1.7 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.6 | 4.5 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.6 | 3.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.5 | 2.7 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.5 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.5 | 1.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.5 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.5 | 18.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.5 | 1.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.5 | 30.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.5 | 11.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.5 | 2.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.5 | 4.9 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.5 | 0.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.5 | 6.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.5 | 3.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.5 | 8.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.5 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.5 | 3.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.5 | 5.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.5 | 1.8 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.4 | 1.8 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.4 | 1.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.4 | 1.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.4 | 2.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.4 | 1.3 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.4 | 144.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.4 | 1.3 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.4 | 5.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.4 | 54.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.4 | 1.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.4 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.4 | 35.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.4 | 1.9 | GO:0031417 | NatC complex(GO:0031417) |
| 0.4 | 0.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 2.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.4 | 1.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.4 | 1.9 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.4 | 0.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 1.5 | GO:0005884 | actin filament(GO:0005884) |
| 0.4 | 7.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.4 | 3.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 9.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 2.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.3 | 7.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.3 | 1.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 10.6 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.3 | 5.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 2.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.3 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.3 | 59.3 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 35.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 4.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.3 | 2.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 31.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 0.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.3 | 3.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.3 | 2.9 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 23.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.3 | 0.9 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.3 | 3.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 1.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.3 | 2.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 1.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 1.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 1.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
| 0.2 | 4.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 3.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 3.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 0.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 1.0 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.2 | 2.9 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 0.7 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 1.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.2 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.2 | 2.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 3.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 1.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.2 | 25.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 3.9 | GO:0001741 | XY body(GO:0001741) |
| 0.2 | 3.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.2 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 0.6 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 0.2 | 0.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.2 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 2.7 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 4.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.2 | 1.3 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 0.6 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.2 | 3.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.2 | 1.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 2.0 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 0.6 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.2 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
| 0.2 | 1.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 1.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.2 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.2 | 1.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.2 | 0.7 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.2 | 0.8 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.2 | 3.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 4.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 1.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 2.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 0.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.1 | 2.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 38.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.1 | 0.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.1 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 1.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 2.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 2.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 2.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.1 | 3.4 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 27.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 1.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 2.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.4 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 0.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 0.7 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.1 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 7.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 0.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 0.4 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 0.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.1 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.3 | GO:0008623 | CHRAC(GO:0008623) |
| 0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.3 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.1 | 1.0 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 10.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 2.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 0.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.1 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.5 | GO:0044754 | autolysosome(GO:0044754) |
| 0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 1.7 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 8.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 1.0 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 16.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.1 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 0.2 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 1.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.3 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 112.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.1 | 2.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 1.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.2 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
| 0.1 | 0.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 0.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 3.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.0 | 3.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 23.4 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 2.5 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.0 | 2.2 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 2.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.2 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.0 | 3.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 1.0 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.0 | 1.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 1.2 | GO:0044440 | endosomal part(GO:0044440) |
| 0.0 | 1.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
| 0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 4.2 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.0 | 4.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 6.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.0 | 2.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 0.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.0 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 7.8 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.4 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 2.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
| 0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.1 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.0 | 0.3 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.2 | GO:0044427 | chromosomal part(GO:0044427) |
| 0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 0.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 7.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 3.7 | 14.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 3.1 | 15.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 2.8 | 11.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.7 | 13.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 2.7 | 16.1 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 2.3 | 23.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 2.3 | 25.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 2.3 | 27.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.2 | 12.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 2.1 | 20.7 | GO:0019863 | IgE binding(GO:0019863) |
| 1.9 | 9.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 1.8 | 9.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.8 | 119.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.8 | 14.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 1.7 | 5.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.7 | 5.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 1.6 | 13.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.6 | 9.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.5 | 4.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.4 | 7.0 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 1.4 | 6.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 1.3 | 6.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.3 | 272.9 | GO:0003823 | antigen binding(GO:0003823) |
| 1.3 | 4.0 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 1.3 | 1.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.3 | 5.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 1.2 | 12.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 1.2 | 3.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.2 | 10.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.2 | 7.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 1.2 | 13.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.1 | 4.6 | GO:0048030 | disaccharide binding(GO:0048030) |
| 1.1 | 5.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 1.1 | 4.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 1.1 | 10.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.1 | 4.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.1 | 12.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 1.1 | 7.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 1.1 | 3.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 1.1 | 3.2 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.0 | 7.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.0 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 1.0 | 3.8 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.9 | 0.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.9 | 1.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.9 | 21.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.8 | 2.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.8 | 5.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.8 | 4.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.8 | 12.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.8 | 2.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.8 | 0.8 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.8 | 13.7 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.8 | 4.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.8 | 17.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.8 | 3.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.7 | 11.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.7 | 9.7 | GO:0019864 | IgG binding(GO:0019864) |
| 0.7 | 3.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.7 | 3.0 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.7 | 3.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.7 | 22.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.7 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.7 | 29.6 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.7 | 2.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.7 | 2.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.7 | 2.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.7 | 6.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.7 | 20.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.7 | 6.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.7 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.7 | 1.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.7 | 2.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.7 | 2.0 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.6 | 1.9 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.6 | 2.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.6 | 3.8 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.6 | 1.9 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.6 | 4.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.6 | 3.1 | GO:0016296 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.6 | 4.3 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.6 | 2.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.6 | 0.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.6 | 19.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.6 | 10.5 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.6 | 1.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.6 | 2.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.6 | 1.7 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.6 | 3.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 1.7 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 1.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.6 | 25.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.6 | 1.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.5 | 1.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.5 | 2.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.5 | 31.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.5 | 2.6 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.5 | 2.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.5 | 3.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.5 | 1.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.5 | 12.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.5 | 4.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.5 | 2.0 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.5 | 1.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.5 | 2.0 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.5 | 1.9 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.5 | 2.9 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.5 | 1.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.5 | 2.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.5 | 4.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.5 | 2.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.4 | 2.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.4 | 4.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.4 | 2.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.4 | 2.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.4 | 1.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.4 | 2.6 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.4 | 3.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.4 | 5.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.4 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.4 | 6.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.4 | 1.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.4 | 1.7 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.4 | 2.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.4 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.4 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.4 | 1.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.4 | 1.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.4 | 0.8 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.4 | 1.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.4 | 1.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 1.2 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.4 | 1.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.4 | 1.6 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.4 | 0.8 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.4 | 3.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 4.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 3.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.4 | 1.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.4 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 2.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.4 | 7.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.4 | 38.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.4 | 2.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.4 | 1.9 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.4 | 3.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.4 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 0.4 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.4 | 3.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.4 | 2.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 0.4 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.4 | 1.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.4 | 0.4 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.4 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 4.3 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.4 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.4 | 8.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.4 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.4 | 3.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.4 | 0.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.4 | 1.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 1.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 1.0 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 0.3 | 1.0 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.3 | 1.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 0.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.3 | 6.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.3 | 1.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.3 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 2.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.3 | 2.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 1.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.3 | 4.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 4.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.3 | 3.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.3 | 2.8 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.3 | 1.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.3 | 1.2 | GO:0019862 | IgA binding(GO:0019862) |
| 0.3 | 16.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.3 | 1.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 0.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.3 | 6.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.3 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.3 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 0.9 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 1.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.3 | 6.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 3.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.3 | 5.5 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.3 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.3 | 3.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.3 | 2.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 0.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.3 | 0.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.3 | 8.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 2.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.3 | 0.8 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.3 | 0.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.3 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.3 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.3 | 1.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.3 | 0.3 | GO:0016298 | lipase activity(GO:0016298) |
| 0.3 | 2.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.3 | 1.1 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.3 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 1.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 2.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.3 | 0.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.3 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.3 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 0.8 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
| 0.3 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 1.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 0.3 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.3 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 1.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 0.7 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.2 | 2.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 0.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 2.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.2 | 5.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 1.0 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
| 0.2 | 0.7 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 3.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 0.7 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.2 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.2 | 15.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.2 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 4.8 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.2 | 1.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.2 | 2.5 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.2 | 1.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 4.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 0.5 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.2 | 1.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 5.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.2 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.2 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.2 | 5.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 1.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 0.7 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.2 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.2 | 0.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 0.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.2 | 2.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 0.9 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.2 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 10.8 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.2 | 0.6 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.2 | 0.2 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.2 | 3.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.2 | 5.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 5.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.2 | 0.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 0.6 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
| 0.2 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 5.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.2 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.2 | 1.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.2 | 0.8 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 3.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 7.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.2 | 3.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 0.8 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.2 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.2 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 0.6 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.2 | 1.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 1.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 0.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.2 | 0.6 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.2 | 0.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.2 | 31.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 5.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 2.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.2 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 8.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 1.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.4 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.2 | 0.5 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.2 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.2 | 3.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.2 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.2 | 0.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.2 | 27.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 2.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 0.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.2 | 0.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.2 | 2.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.2 | 0.5 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 2.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 2.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 1.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.2 | 0.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.2 | 3.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.8 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.2 | 0.5 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.2 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 0.8 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 1.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.2 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 0.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 6.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 1.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.2 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 0.8 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 0.5 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.2 | 0.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.2 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.2 | 4.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 0.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.2 | 1.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 2.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 4.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.4 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.1 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 0.6 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.1 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.4 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.1 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.1 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 2.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 2.9 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 50.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.4 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 2.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 2.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 4.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 3.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.1 | 2.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.1 | 2.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 0.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 1.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 2.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 2.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 3.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 1.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 0.6 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 4.9 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.1 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.1 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.2 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
| 0.1 | 14.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 2.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 4.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.2 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.1 | 0.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 1.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 1.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 24.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 3.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.1 | 2.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 0.3 | GO:0036393 | thiocyanate peroxidase activity(GO:0036393) |
| 0.1 | 0.3 | GO:0005496 | steroid binding(GO:0005496) |
| 0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
| 0.1 | 0.3 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.1 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 0.7 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 2.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.1 | 0.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 2.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 5.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 0.9 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 1.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 3.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.1 | 0.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.1 | 0.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 0.4 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.1 | 0.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.1 | 0.4 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.1 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 1.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 3.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 9.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.1 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 2.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 2.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 2.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 2.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 0.3 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 3.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.1 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 2.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 1.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 4.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 2.2 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.1 | 0.3 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 1.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.5 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 0.3 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 4.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.1 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.2 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 0.1 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 6.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 1.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.1 | 2.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.2 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.3 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.1 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 0.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.4 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.0 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.0 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.0 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 3.6 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.0 | 0.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 0.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 3.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.0 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
| 0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.0 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.0 | 7.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.2 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.0 | 1.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.4 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
| 0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 1.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.0 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 1.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 2.5 | GO:0032934 | sterol binding(GO:0032934) |
| 0.0 | 0.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.5 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.0 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.0 | 7.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.0 | 0.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 6.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.0 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 1.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.0 | 0.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.0 | 0.1 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.0 | 0.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 2.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.3 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.0 | 0.3 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 0.0 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 0.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 0.1 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.0 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.0 | 0.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.3 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.1 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.0 | 6.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.1 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 0.0 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
| 0.0 | 0.1 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.0 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.0 | 0.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 4.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 57.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 43.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.6 | 22.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.6 | 21.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.6 | 14.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.6 | 6.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.5 | 68.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.5 | 45.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 2.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.5 | 20.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.5 | 24.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.5 | 34.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.5 | 23.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.4 | 14.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.4 | 2.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.4 | 11.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 3.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 6.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 3.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 12.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.3 | 17.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 4.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 2.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 12.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.3 | 15.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 6.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.3 | 84.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.3 | 8.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 18.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 3.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 2.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.3 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 3.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 10.2 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 2.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 7.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 2.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 77.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 6.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 14.7 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 19.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.2 | 3.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 3.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 5.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 5.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 11.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 3.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 4.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 8.4 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 16.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 1.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 1.9 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 5.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 5.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 3.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 4.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 7.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 2.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 2.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 3.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 3.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 3.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 7.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 2.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 2.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 2.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 3.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 12.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.3 | 1.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.3 | 39.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.2 | 139.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.1 | 23.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 1.0 | 70.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.9 | 0.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.7 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.7 | 26.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.7 | 26.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.7 | 25.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.6 | 21.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.6 | 14.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.6 | 7.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.6 | 11.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.6 | 3.9 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.6 | 28.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.6 | 5.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.5 | 17.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.5 | 3.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.5 | 12.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.4 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.4 | 9.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 1.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.4 | 9.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 4.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.4 | 3.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.4 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.4 | 7.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.4 | 3.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.4 | 35.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.4 | 4.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.4 | 9.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.4 | 4.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 8.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.4 | 10.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 1.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.3 | 9.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 7.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.3 | 4.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.3 | 18.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 14.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 9.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.3 | 4.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.3 | 46.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.3 | 6.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.3 | 32.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.3 | 8.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 4.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 1.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 4.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 5.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 5.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 8.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 3.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.2 | 12.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 4.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 2.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.2 | 4.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.2 | 8.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 1.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.2 | 3.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.2 | 9.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 3.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 8.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
| 0.2 | 4.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 5.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.2 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 4.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 2.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 16.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 4.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 1.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.2 | 7.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 4.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.2 | 2.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 0.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 3.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 6.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.1 | 6.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 1.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 2.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 6.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 2.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 5.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 1.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 10.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 3.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.1 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 2.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 3.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 2.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 2.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 8.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 2.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 15.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 4.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 1.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 1.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 4.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.1 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.1 | 2.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 15.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 1.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 0.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 2.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 3.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 3.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.0 | 1.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 1.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 1.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.9 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.0 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 1.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |